Clinical Manifestations and Genetic Influences in Sulfonamide-Induced Hypersensitivity

References

• Johansson SGO, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113(5):832–836. doi:10.1016/j.jaci.2003.12.591
   PubMed Web of Science ®Google Scholar
• Pichler WJ, Yerly D. Drug hypersensitivity: we need to do more. J Allergy Clin Immunol. 2018;141(1):89–91. doi:10.1016/j.jaci.2017.11.002
   PubMed Web of Science ®Google Scholar
• Tsai YG, Chung WH, Abe R, Tassaneeyakul W. New advances in drug hypersensitivity research and treatment. J Immunol Res. 2018;2018:2–4. doi:10.1155/2018/9345078
   Web of Science ®Google Scholar
• Tanno LK, Bierrenbach AL, Simons FER, et al. Critical view of anaphylaxis epidemiology: open questions and new perspectives. Allergy Asthma Clin Immunol. 2018;14(1):2. doi:10.1186/s13223-018-0234-0
   PubMed Web of Science ®Google Scholar
• Thong BYH, Tan TC. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol. 2011;71(5):684–700. doi:10.1111/j.1365-2125.2010.03774.x
   PubMed Web of Science ®Google Scholar
• Ratajczak HV. Drug-induced hypersensitivity: role in drug development. Toxicol Rev. 2004;23(4):265–280. doi:10.2165/00139709-200423040-00006
   PubMedGoogle Scholar
• Shah F, Bell IM. Cutaneous adverse events caused by sulfonamide-containing drugs: reality or perception? J Med Chem. 2020;63(14):7447–7457. doi:10.1021/acs.jmedchem.9b01932
   PubMed Web of Science ®Google Scholar
• Tacic A, Nikolic V, Nikolic L, Savic I. Antimicrobial sulfonamide drugs. Adv Technol. 2017;6(1):58–71. doi:10.5937/savteh1701058t
   Google Scholar
• Castells M, Santos-Bonamichi R. Drug Hypersensitivity. Elsevier Ltd; 2019. Vol. 2. doi:10.1002/9781444300918.ch94
   Google Scholar
• Gruchalla RS. Drug Allergy. J Allergy Clin Immunol. 2003;111(2):548–559. doi:10.1067/mai.2003.93
   Google Scholar
• García-Galán MJ, Silvia Díaz-Cruz M, Barceló D. Identification and determination of metabolites and degradation products of sulfonamide antibiotics. TrAC - Trends Anal Chem. 2008;27(11):1008–1022. doi:10.1016/j.trac.2008.10.001
   Web of Science ®Google Scholar
• Giles A, Foushee J, Lantz E, Gumina G. Sulfonamide Allergies. Pharmacy. 2019;7(3):132. doi:10.3390/pharmacy7030132
   Web of Science ®Google Scholar
• Khan DA, Knowles SR, Shear NH. Sulfonamide Hypersensitivity: fact and Fiction. J Allergy Clin Immunol Pract. 2021;7(7):2116–2123. doi:10.1016/j.jaip.2019.05.034
   Web of Science ®Google Scholar
• Jung J, Kim J, Park I, Choi B, Kang H. Genetic markers of severe cutaneous adverse reactions. Korean J Intern Med. 2018;33(5):867–875. doi:10.3904/kjim.2018.126
   PubMed Web of Science ®Google Scholar
• Carr A, Swanson C, Penny R, Cooper DA. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with pneumocystis carinii pneumonia and AIDS. J Infect Dis. 1993;167(1):180–185. doi:10.1093/infdis/167.1.180
   PubMed Web of Science ®Google Scholar
• Nakamura R, Ozeki T, Hirayama N, et al. Association of HLA-A*11:01 with sulfonamide-related severe cutaneous adverse reactions in Japanese patients. J Invest Dermatol. 2020;140:1659–1662.e6. doi:10.1016/j.jid.2019.12.025
   PubMed Web of Science ®Google Scholar
• Reinhart JM, Motsinger-Reif A, Dickey A, Yale S, Trepanier LA. Genome-wide association study in immunocompetent patients with delayed hypersensitivity to sulfonamide antimicrobials. PLoS One. 2016;11(6):1–15. doi:10.1371/journal.pone.0156000
   Web of Science ®Google Scholar
• Özkaya-Bayazit E, Akar U. Fixed Drug Eruption induced by trimethoprim-sulfamethoxazole: evidence for a Link to HLA-A30 B13 Cw6 Haplotype. J Am Acad Dermatol. 2001;45(5):712–717. doi:10.1067/mjd.2001.117854
   PubMed Web of Science ®Google Scholar
• Potocnik E, Drozdzewska K, Schwarz B. Presumed sulfonamide-associated uveitis with Stevens-Johnson Syndrome in a quarter horse mare. J Equine Vet Sci. 2019;77:17–22. doi:10.1016/j.jevs.2019.02.004
   PubMed Web of Science ®Google Scholar
• Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol. 2005;53(3):373–388. doi:10.1016/j.jaad.2004.09.032
   PubMed Web of Science ®Google Scholar
• Greaves M, Lawlor F. Angioedema: manifestations and management. J Am Acad Dermatol. 1991;25(1):155–165. doi:10.1016/0190-9622(91)70183-3
   PubMed Web of Science ®Google Scholar
• Bas M, Hoffmann TK, Kojda G. Evaluation and management of angioedema of the head and neck. Curr Opin Otolaryngol Head Neck Surg. 2006;14(3):170–175. doi:10.1097/01.moo.0000193202.85837.7d
   PubMedGoogle Scholar
• Brown SGA. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004;114(2):371–376. doi:10.1016/j.jaci.2004.04.029
   PubMed Web of Science ®Google Scholar
• Bernstein JA, Moellman J. Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema. Int J Emerg Med. 2012;5(1):1. doi:10.1186/1865-1380-5-39
   PubMedGoogle Scholar
• Tarbox A, Bansal J, Peiris AN. Angioedema. JAMA. 2018;319(19):2054. doi:10.1001/jama.2018.4860
   PubMedGoogle Scholar
• Jabs D, Nussenblatt RB, Rosenbaum JT. Perspectives standardization of uveitis nomenclature for reporting clinical data. Am J Ophthalmol. 2005;140:509–516. doi:10.1016/j.ajo.2005.03.057
   PubMed Web of Science ®Google Scholar
• Cordero-coma M, Salazar-m R, Garzo-garcı I. Drug-induced uveitis. Expert Opin Drug Saf. 2015:1–16. DOI:10.1517/14740338.2015.972363
   Web of Science ®Google Scholar
• Mindel J, Uveitis D. Therapeutic Review. Clin Ther. 1998;42:6.
   Google Scholar
• Morris E, Rosenbaum JT, Fraunfelder FT. Systemic Sulfonamides as a Cause of Bilateral, Anterior Uveitis. Arch Ophthalmol. 2015;109:67–69.
   Google Scholar
• Agarwal M, Majumder P, Babu K, et al. Drug-Induced Uveitis: a Review. Indian J Ophthalmol. 2020;68(9):1799–1807. doi:10.4103/ijo.IJO_816_20
   PubMed Web of Science ®Google Scholar
• Moorthy RS, London NJS, Garg SJ. Drug-Induced Uveitis. Curr Opin Ophthalmol. 2013:589–597. DOI:10.1097/01.icu.0000434534.32063.5c
   PubMed Web of Science ®Google Scholar
• Pichler WJ. Drug Hypersensitivity. 5th ed. Elsevier Ltd; 2009. Vol. 2. doi:10.1002/9781444300918.ch94
   Google Scholar
• NIH. Rashes. Available from: https://medlineplus.gov/rashes.html. Accessed June 9, 2021.
   Google Scholar
• Jr DAD, Montanaro A. Allergies to sulfonamide antibiotics and sulfur- containing drugs. Ann Allergy Asthma Immunol. 2008;100(2):91–101. doi:10.1016/S1081-1206(10)60415-2
   PubMed Web of Science ®Google Scholar
• Schnyder B, Pichler WJ. Allergy to Sulfonamides. J Allergy Clin Immunol. 2013;131(1):256–257.e5. doi:10.1016/j.jaci.2012.10.003
   PubMed Web of Science ®Google Scholar
• Zawodniak A, Lochmatter P, Beeler A, Pichler WJ. Cross-reactivity in drug hypersensitivity reactions to sulfasalazine and sulfamethoxazole. Int Arch Allergy Immunol. 2010;153:152–156. doi:10.1159/000312632
   PubMed Web of Science ®Google Scholar
• Neuman MG, Shear NH, Malkiewicz IM, et al. Immunopathogenesis of hypersensitivity syndrome. Transl Res. 2007:243–253. DOI:10.1016/j.trsl.2006.12.001
   PubMed Web of Science ®Google Scholar
• Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and Toxic Epidermal Necrolysis. Expert Rev Clin Immunol. 2011;7(6):803–815. doi:10.1586/eci.11.66
   PubMed Web of Science ®Google Scholar
• Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on Stevens-Johnson Syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018;54(1):147–176. doi:10.1007/s12016-017-8654-z
   PubMed Web of Science ®Google Scholar
• Davis WD, Schafer PA. Stevens-Johnson Syndrome: a challenging diagnosis. Adv Emerg Nurs J. 2018;40(3):176–182. doi:10.1097/TME.0000000000000197
   PubMed Web of Science ®Google Scholar
• Daniel BS, Joly P, Murrell DF. Management of erythema multiforme, Stevens-Johnson Syndrome and toxic epidermal necrolysis. Blistering Dis Clin Featur Pathog Treat. 2015;617–622. doi:10.1007/978-3-662-45698-9_66
   Google Scholar
• Guillaume J-C, Roujeau J-C, Revuz J, Penso D, Touraine R. The Culprit Drugs in 87 Cases of Toxic Epidermal Necrolysis (Lyell’s Syndrome). Arch Dermatol. 1987;123:1166–1170.
   PubMedGoogle Scholar
• Harris V, Jackson C, Cooper A. Review of Toxic Epidermal Necrolysis. Int J Mol Sci. 2016;17(12):1–11. doi:10.3390/ijms17122135
   Web of Science ®Google Scholar
• Paquet P, Piérard GE, Quatresooz P. Novel treatments for drug-induced toxic epidermal necrolysis (Lyell’s Syndrome). Int Arch Allergy Immunol. 2005;136(3):205–216. doi:10.1159/000083947
   PubMed Web of Science ®Google Scholar
• Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau J-C. Clinical classification of cases of toxic syndrome, and erythema multiforme. Arch Dermatol. 1993;129(1):92–96. doi:10.1001/archderm.1993.01680220104023
   PubMedGoogle Scholar
• Komatsu-Fujii T, Kaneko S, Chinuki Y, et al. Serum TARC levels are strongly correlated with blood eosinophil count in patients with drug eruptions. Allergol Int. 2017;66(1):116–122. doi:10.1016/j.alit.2016.06.003
   PubMed Web of Science ®Google Scholar
• Wildermuth A. Stevens-Johnson Syndrome and toxic epidermal necrolysis. J Am Acad Physician Assist. 2020;33(8):48–49. doi:10.1097/01.JAA.0000684164.28009.4a
   Google Scholar
• Fernando SL. The management of toxic epidermal necrolysis. Australas J Dermatol. 2012;53(3):165–171. doi:10.1111/j.1440-0960.2011.00862.x
   PubMed Web of Science ®Google Scholar
• Cummins JM, Rago C, Kohli M, Kinzler KW, Lengauer C, Vogelstein B. A marker for Stevens–Johnson Syndrome. Nature. 2004;428(6982):2501. doi:10.1038/nature02501
   Web of Science ®Google Scholar
• Sehic A, Haenig C, Spear F. An unusual case of acute parotitis in a young adult. J Am Acad Physician Assist. 2017;30(8):27–29. doi:10.1097/01.JAA.0000521134.30915.a9
   Google Scholar
• Patel JS, Scheiner ED. Acute parotitis induced by trimethoprim/Sulfamethoxazole. Ear, Nose Throat J. 2011;90:2. doi:10.1177/014556131109000214
   Google Scholar
• Baer AN, Okuhama A, Eisele DW, Tversky JR, Gniadek TJ. Eosinophilic Sialodochitis: redefinition of ‘Allergic Parotitis’ and ‘Sialodochitis Fibrinosa. Oral Dis. 2017;23(7):840–848. doi:10.1111/odi.12595
   PubMed Web of Science ®Google Scholar
• Wu S, Shi H, Cao N, Ye L, Yu C, Zheng L. The correlation of immunologic derangement and juvenile recurrent parotitis: an investigation of the laboratory immunological observation. Acta Otolaryngol. 2018;138(12):1112–1116. doi:10.1080/00016489.2018.1515498
   PubMed Web of Science ®Google Scholar
• Taguchi M, Yokota M, Koyano H, Endo Y, Ozawa Y. Acute pancreatitis induced by methimazole in a patient with graves’ disease. Clin Endocrinol. 1999;51(1):667–670. doi:10.1089/thy.2011.0210
   PubMed Web of Science ®Google Scholar
• Sasi S, Altarawneh H, Petkar MA, Nair AP. Drug reaction with eosinophilia and systemic symptoms secondary to naproxen: a case report and literature review. Case Reports Acute Med. 2020;3(2):63–72. doi:10.1159/000509712
   Google Scholar
• Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia. 2007;48(7):1223–1244. doi:10.1111/j.1528-1167.2007.01041.x
   PubMed Web of Science ®Google Scholar
• Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): an original multisystem adverse drug reaction. results from the prospective RegiSCAR study. Br J Dermatol. 2013;169(5):1071–1080. doi:10.1111/bjd.12501
   PubMed Web of Science ®Google Scholar
• Velema MS, Voerman HJ. DRESS Syndrome Caused by Nitrofurantoin. Neth J Med. 2009;67(4):147–149.
   PubMed Web of Science ®Google Scholar
• Boyd A, Mills D, Hook K, Kaila R. Seventeen-year-old sexually active male with rash. Am J Emerg Med. 2016;34(4):764.e1–764.e3. doi:10.1016/j.ajem.2015.08.043
   Web of Science ®Google Scholar
• Cho YT, Yang CW, Chu CY. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): an interplay among drugs, viruses, and immune system. Int J Mol Sci. 2017;18:6. doi:10.3390/ijms18061243
   Web of Science ®Google Scholar
• Sharifzadeh S, Mohammadpour AH, Tavanaee A, Elyasi S. Antibacterial Antibiotic-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome: a literature review. Eur J Clin Pharmacol. 2021;77(3):275–289. doi:10.1007/s00228-020-03005-9
   PubMed Web of Science ®Google Scholar
• Misery L, Stander S. Pruritus. London: Springer; 2010.
   Google Scholar
• Tivoli Y, Rubenstein R. Pruritus. J Clin Aesthet Dermatol. 2009;2(7):30–36.
   PubMedGoogle Scholar
• Song J, Xian D, Yang L, Xiong X, Lai R, Zhong J. Pruritus: progress toward pathogenesis and treatment. Biomed Res Int. 2018;2018:1–12. doi:10.1155/2018/9625936
   Web of Science ®Google Scholar
• Elzagallaai A, Sultan E, Bend J, Abuzgaia A, Loubani E, Rieder M. Role of oxidative stress in hypersensitivity reactions to sulfonamides. J Clin Pharmacol. 2019;1–13. doi:10.1002/jcph.1535
   Web of Science ®Google Scholar
• Nowak D, Yeung J. Diagnosis and Treatment of Pruritus. Can Fam Physician. 2017;63(12):918–924.
   PubMed Web of Science ®Google Scholar
• Yang T-LB, Kim BS. Pruritus in allergy and immunology. J Allergy Clin Immunol. 2019;144(2):353–360. doi:10.1016/j.jaci.2019.06.016
   PubMed Web of Science ®Google Scholar
• Ebata T. Drug-induced itch management. Curr Probl Dermatol. 2016;50:155–163. doi:10.1159/000446084
   PubMedGoogle Scholar
• Lonjou C, Borot N, Sekula P, et al. A European study of HLA-B in Stevens – Johnson Syndrome and Toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics. 2008;18:99–107. doi:10.1097/FPC.0b013e3282f3ef9c
   PubMed Web of Science ®Google Scholar
• Roujeau J-C, Hundh T, Bracq C, Guillaume J-C, Revuz J, Touraine R. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol. 2015;2015:8–10.
   Google Scholar
• Howell WM, Carter V, Clark B. The HLA system: immunobiology, HLA typing, antibody screening and crossmatching techniques. J Clin Pathol. 2010;63. 387–391. doi:10.1136/jcp.2009.072371
   PubMed Web of Science ®Google Scholar
• Mosaad YM. Clinical role of human leukocyte antigen in health and disease. Scand J Immunol. 2015;82:283–306. DOI:10.1111/sji.12329
   PubMed Web of Science ®Google Scholar
• Lund O, Nielsen M, Kesmir C, et al. Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics. 2004;55:797–810. doi:10.1007/s00251-004-0647-4
   PubMed Web of Science ®Google Scholar
• Pichler WJ. Delayed drug hypersensitivity reactions. PLoS One. 2013;683–693.
   Google Scholar
• Fischer PR, Shigeoka A. Familial occurrence of Steven Johnson Syndrome. AJDC. 1983;137:914–916. doi:10.1001/archpedi.1983.02140350086023
   PubMedGoogle Scholar